390 related articles for article (PubMed ID: 10822117)
1. Statistical considerations in the intent-to-treat principle.
Lachin JM
Control Clin Trials; 2000 Jun; 21(3):167-89. PubMed ID: 10822117
[TBL] [Abstract][Full Text] [Related]
2. Statistical properties of randomization in clinical trials.
Lachin JM
Control Clin Trials; 1988 Dec; 9(4):289-311. PubMed ID: 3060315
[TBL] [Abstract][Full Text] [Related]
3. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
Wang Y; Berlin JA; Pinheiro J; Wilcox MA
Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
[TBL] [Abstract][Full Text] [Related]
4. Properties of permuted-block randomization in clinical trials.
Matts JP; Lachin JM
Control Clin Trials; 1988 Dec; 9(4):327-44. PubMed ID: 3203524
[TBL] [Abstract][Full Text] [Related]
5. The mixed model for repeated measures for cluster randomized trials: a simulation study investigating bias and type I error with missing continuous data.
Bell ML; Rabe BA
Trials; 2020 Feb; 21(1):148. PubMed ID: 32033617
[TBL] [Abstract][Full Text] [Related]
6. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
Salim A; Mackinnon A; Christensen H; Griffiths K
Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
[TBL] [Abstract][Full Text] [Related]
7. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
8. Bias reduction with an adjustment for participants' intent to dropout of a randomized controlled clinical trial.
Leon AC; Demirtas H; Hedeker D
Clin Trials; 2007; 4(5):540-7. PubMed ID: 17942469
[TBL] [Abstract][Full Text] [Related]
9. Correction for non-compliance in equivalence trials.
Robins JM
Stat Med; 1998 Feb; 17(3):269-302; discussion 387-9. PubMed ID: 9493255
[TBL] [Abstract][Full Text] [Related]
10. Statistical issues in interpreting clinical trials.
DeMets DL
J Intern Med; 2004 May; 255(5):529-37. PubMed ID: 15078496
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity analysis for the estimation of rates of change with non-ignorable drop-out: an application to a randomized clinical trial of the vitamin D3.
Matsuyama Y
Stat Med; 2003 Mar; 22(5):811-27. PubMed ID: 12587107
[TBL] [Abstract][Full Text] [Related]
12. The impact of randomization on the analysis of clinical trials.
Rosenkranz GK
Stat Med; 2011 Dec; 30(30):3475-87. PubMed ID: 21953285
[TBL] [Abstract][Full Text] [Related]
13. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
[TBL] [Abstract][Full Text] [Related]
14. Group comparisons involving missing data in clinical trials: a comparison of estimates and power (size) for some simple approaches.
Miller ME; Morgan TM; Espeland MA; Emerson SS
Stat Med; 2001 Aug; 20(16):2383-97. PubMed ID: 11512129
[TBL] [Abstract][Full Text] [Related]
15. "Just Another Statistic".
Machtay M; Glatstein E
Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
[TBL] [Abstract][Full Text] [Related]
16. Assessing the impact of selection bias on test decisions in trials with a time-to-event outcome.
Rückbeil MV; Hilgers RD; Heussen N
Stat Med; 2017 Jul; 36(17):2656-2668. PubMed ID: 28417471
[TBL] [Abstract][Full Text] [Related]
17. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
Sheng D; Kim MY
Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
[TBL] [Abstract][Full Text] [Related]
18. Properties of simple randomization in clinical trials.
Lachin JM
Control Clin Trials; 1988 Dec; 9(4):312-26. PubMed ID: 3203523
[TBL] [Abstract][Full Text] [Related]
19. Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group.
Chêne G; Morlat P; Leport C; Hafner R; Dequae L; Charreau I; Aboulker JP; Luft B; Aubertin J; Vildé JL; Salamon R
Control Clin Trials; 1998 Jun; 19(3):233-48. PubMed ID: 9620807
[TBL] [Abstract][Full Text] [Related]
20. Is using multiple imputation better than complete case analysis for estimating a prevalence (risk) difference in randomized controlled trials when binary outcome observations are missing?
Mukaka M; White SA; Terlouw DJ; Mwapasa V; Kalilani-Phiri L; Faragher EB
Trials; 2016 Jul; 17():341. PubMed ID: 27450066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
